Filippo Severin

7PUBLICATIONS
27CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 04, 2026
Organelle contact sites in cancer cells.

Ilaria Celotti, Matteo Scavezzon, Sabrina Toffanin

|Mar 13, 2024
The Role of Transglutaminase 2 in Cancer: An Update.

Elisabetta Zaltron, Federica Vianello, Alessia Ruzza

|Oct 29, 2023
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma.

Silvia Muccioli, Valentina Brillo, Tatiana Varanita

|May 16, 2023
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?

Nayla Mouawad, Guido Capasso, Edoardo Ruggeri

|Nov 13, 2021
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia.

Federica Frezzato, Andrea Visentin, Filippo Severin

|Oct 16, 2020
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia.

Andrea Visentin, Federica Frezzato, Filippo Severin

Pageof 2